HCA
PFE icon

Harbor Capital Advisors’s Pfizer PFE Stock Holding History

Harbor Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
66,351
-613
-0.9% -$16K 0.11% 263
2026
Q1 		$1.88M Sell
66,964
-23,754
-26% -$632K 0.15% 198
2025
Q4 		$2.26M Sell
90,718
-69
-0.1% -$1.74K 0.18% 152
2025
Q3 		$2.31M Buy
90,787
+2,901
+3% +$71.6K 0.18% 154
2025
Q2 		$2.13M Buy
87,886
+72
+0.1% +$1.68K 0.09% 285
2025
Q1 		$2.23M Sell
87,814
-26,685
-23% -$698K 0.1% 266
2024
Q4 		$3.04M Buy
114,499
+2,805
+3% +$76.1K 0.13% 215
2024
Q3 		$3.23M Buy
111,694
+535
+0.5% +$15.6K 0.14% 207
2024
Q2 		$3.11M Buy
111,159
+214
+0.2% +$5.89K 0.24% 120
2024
Q1 		$3.08M Buy
110,945
+13,462
+14% +$374K 0.4% 36
2023
Q4 		$2.81M Sell
97,483
-177
-0.2% -$5.35K 0.54% 32
2023
Q3 		$3.24M Hold
97,660
– – 0.69% 22
2023
Q2 		$3.58M Hold
97,660
– – 0.72% 19
2023
Q1 		$3.98M Buy
97,660
+96,031
+5,895% +$4.15M 1.15% 21
2022
Q4 		$83.5K Sell
1,629
-221
-12% -$10.6K 0.08% 101
2022
Q3 		$81K Sell
1,850
-1,250
-40% -$60.7K 0.07% 101
2022
Q2 		$163K Sell
3,100
-302
-9% -$15.4K 0.12% 93
2022
Q1 		$176K Buy
+3,402
New +$177K 0.08% 104

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Harbor Capital Advisors's PFE Position: Q2 2026 in Review

Harbor Capital Advisors reduced its Pfizer (PFE) stake by 0.92% in Q2 2026, selling an estimated $16K and leaving 66,351 shares worth $1.6M. The position accounts for 0.11% of the portfolio, ranked #263.

Harbor Capital Advisors first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.98M in Q1 2023. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Harbor Capital Advisors held 66,351 shares of Pfizer worth $1.6M as of Q2 2026.
  • Harbor Capital Advisors sold 613 Pfizer shares in Q2 2026, an estimated $16K.
  • Pfizer made up 0.11% of Harbor Capital Advisors's portfolio in Q2 2026, its #263 holding.
  • Harbor Capital Advisors first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
  • Harbor Capital Advisors's Pfizer position peaked at $3.98M in Q1 2023.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.